Smart Ring Maker Oura Aims to Raise ₹18,300 Crore in US IPO
Oura, the company behind the popular smart health tracking ring, is planning to raise up to ₹18,300 crore (approximately $2.2 billion) through its Initial Public Offering (IPO) in the United States. Existing investors and the company will sell 50 million shares, with a price range set between $40 and $44 per share. Pharmaceutical giant Eli Lilly and investment firm Dragoneer have expressed interest in buying shares.
Key takeaways
- Oura, the smart ring maker, plans to raise up to ₹18,300 crore in its US IPO.
- Shares will be priced between $40 and $44, with 50 million shares offered.
- Eli Lilly and Dragoneer have shown interest in buying shares.
- This IPO reflects strong investor interest in health technology and wearable devices.
Smart ring manufacturer Oura is set to launch its Initial Public Offering (IPO) in the United States, with an ambitious target of raising up to ₹18,300 crore (approximately $2.2 billion). The company, known for its innovative smart rings that monitor crucial health indicators like heart rate and sleep patterns, is offering 50 million shares to the public.
IPO Details and Investor Interest
The shares are expected to be priced in a range of $40 to $44 each. This offering will include shares sold by Oura itself, alongside those from some of its existing investors. Notably, two significant entities, pharmaceutical giant Eli Lilly and investment firm Dragoneer, have already indicated their interest in purchasing shares during the IPO.
What is Oura?
Oura Health Oy is a Finnish health technology company that develops and manufactures the Oura Ring, a wearable device designed to track sleep, activity, and overall health. The ring collects data on heart rate, heart rate variability, body temperature, and movement, providing users with insights into their well-being through a companion app. It has gained popularity among health enthusiasts and athletes for its discreet design and comprehensive health tracking capabilities.
Implications for Global Markets
This IPO marks a significant event in the wearable technology and health tech sectors. A successful listing could provide Oura with substantial capital to further its research and development, expand its product offerings, and increase its market penetration globally. For Indian investors tracking global markets, Oura's IPO offers a glimpse into the valuation trends and investor appetite for innovative health technology companies.
Why This Matters for Indian Readers
While this is a US-based IPO, the performance of companies like Oura on international exchanges can influence investor sentiment towards similar technology and health-focused companies in India. It also highlights the growing global trend of integrating technology into personal health management, a trend that is increasingly visible in the Indian market with the rise of fitness trackers and smart wearables.
This report is for informational purposes only and does not constitute investment advice.
Frequently asked questions
What is Oura and what does it do?
Oura is a Finnish health technology company that makes a smart ring. This ring tracks key health indicators like heart rate, sleep patterns, and body temperature to provide users with insights into their well-being.
How much money is Oura looking to raise in its IPO?
Oura aims to raise up to ₹18,300 crore (approximately $2.2 billion) through its Initial Public Offering in the United States.
Who are the key investors interested in Oura's IPO?
Pharmaceutical company Eli Lilly and investment firm Dragoneer have indicated their interest in purchasing shares in Oura's IPO.